Propylthiouracil Information
Propylthiouracil is indicated:
- in patients with Graves’ disease with hyperthyroidism or toxic multinodular goiter who are intolerant of methimazole and for whom surgery or radioactive iodine therapy is not an appropriate treatment option
- to ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy in patients who are intolerant of methimazole
Related Information
- FDA Drug Safety Communication: New Boxed Warning on severe liver injury with propylthiouracil
- Information for Healthcare Professionals - Propylthiouracil-Induced Liver Failure
- FDA Patient Safety News: Show #89, August 2009
- Propylthiouracil